Ophthalmology Times Europe July/August 2022

Recent identification of the BCO2 gene and the Aster-B transport protein gives insight into carotenoid distribution in the retina.

A short course of a low-dose corticosteroid eye drop can relieve inflammation with only a low increase in intraocular pressure.

Although the standard of care remains the pharmaceutical option, surgeons would like to see other options for individualised treatment, including artificial intelligence and sustained-release technologies.

One systematic review and meta-analysis finds bariatric surgery associated with fewer cases of diabetic retinopathy overall and of sight-threatening progression.

Moving past the eyes and into the brain: It is vital to think beyond the eye in the presence of visual impairment and blindness.

Zonular crises occur due to many different aetiologies, but ophthalmologists now have multiple tools available to solve complex problems and achieve excellent results in complex cases.

Genotyping and artificial intelligence are together starting to predict the progression of glaucoma in individual patients, sparing them from suboptimal treatments and side effects. Recent research efforts are exploring modifiable risk factors such as caffeine consumption.

Recent reports of retinal atrophy have raised concerns on potential long-term safety.